Search for: "High Liquors LLC"
Results 41 - 47
of 47
Sorted by Relevance
|
Sort by Date
25 Apr 2011, 4:55 am
(IP Dragon) Intellectual Property Bank in Taiwan and China (but very different) (IP Dragon) On counterfeit liquor and wine (IP Dragon) The lay-out of the Magic Kingdom in Shanghai wrapped up in a trade secret (IP Dragon) Tsingtao Beer China’s well known trademark (IP Dragon) China: Do just one thing. [read post]
27 Feb 2015, 5:44 am
”); Mayhue’s Super Liquor Stores, Inc. v. [read post]
27 Feb 2015, 5:44 am
”); Mayhue’s Super Liquor Stores, Inc. v. [read post]
14 Apr 2015, 1:56 pm
Choose from the 10-40 ($14) [Recipe: 2 oz Tequila Tapatio B110, 1 oz Liquor 43, 8 drops orange flower water. [read post]
13 Mar 2009, 4:00 am
(Innovationpartners) Europe ECJ: No simple test for bad faith trade mark registration: Chocoladefabriken Lindt & Sprüngli AG v Franz Hauswirth GmbH (IPKat) Court of First Instance: Shells all too common in bakery and confectionery sector: G M Piccolo Srl v OHIM (Class 46) European Parliament votes for greater ACTA transparency (Michael Geist) (Ars Technica) CTM fees to be reduced (Class 46) (Class 46) (Class 46) (BLOG@IP::JUR) (The IP Factor) (Out-Law) (Law360) … [read post]
30 Mar 2021, 6:51 am
The governor’s bill would result in a net tax cut of $185 million a year, but that represents about $477 million in tax cuts for individuals and a $292 million tax increase for businesses.[3] In broad outlines, the governor proposes to reduce wage income taxes dramatically by raising the sales tax rate, expanding the sales tax base to business purchases, implementing a luxury tax, substantially raising excise taxes, and hiking severance taxes.[4] Specifically, the plan includes: An… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) – Lundbeck wins… [read post]
